192.04

0.70% -1.27

Astrazeneca Plc (AZN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché AZN Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$193.31

Aprire:

$193.91

Volume 24 ore:

1.85M

Relative Volume:

0.36

Capitalizzazione di mercato:

$297.83B

Reddito:

$58.80B

Utile/perdita netta:

$10.24B

Rapporto P/E:

58.57

EPS:

3.2788

Flusso di cassa netto:

$8.98B

1 W Prestazione:

-2.81%

1M Prestazione:

-6.14%

6M Prestazione:

+141.28%

1 anno Prestazione:

+154.02%

Intervallo 1D:

$190.96

$193.92

Intervallo di 1 settimana:

$189.35

$198.09

Portata 52W:

$61.24

$212.71

Astrazeneca Plc Stock (AZN) Company Profile

Nome

Astrazeneca Plc

Settore

Healthcare (1115)

Industria

Drug Manufacturers - General (20)

Telefono

Indirizzo

Dipendente

96,100

Cinguettio

@AstraZeneca

Prossima data di guadagno

2026-02-10

Ultimi documenti SEC

AZN's Discussions on Twitter

Compare AZN vs LLY, JNJ, ABBV, NVS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AZN Astrazeneca Plc	192.05	299.79B	58.80B	10.24B	8.98B	3.2788
LLY Lilly Eli Co	978.52	892.85B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	243.20	585.58B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	225.57	402.58B	61.16B	4.19B	17.82B	2.3614
NVS Novartis Ag Adr	154.23	297.29B	54.72B	14.02B	15.32B	7.1855

Astrazeneca Plc Stock (AZN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-27	Iniziato	Citigroup	Buy
2025-10-27	Ripresa	Jefferies	Buy
2025-10-16	Downgrade	Deutsche Bank	Hold → Sell
2025-04-15	Iniziato	Exane BNP Paribas	Outperform
2025-02-13	Aggiornamento	UBS	Neutral → Buy
2025-02-12	Iniziato	Morgan Stanley	Overweight
2024-11-20	Aggiornamento	UBS	Sell → Neutral
2024-11-06	Aggiornamento	Deutsche Bank	Sell → Hold
2024-09-13	Downgrade	Deutsche Bank	Hold → Sell
2024-05-30	Iniziato	Goldman	Buy
2024-04-16	Aggiornamento	Deutsche Bank	Sell → Hold
2024-02-08	Downgrade	Deutsche Bank	Hold → Sell
2024-01-23	Iniziato	Morgan Stanley	Overweight
2024-01-16	Ripresa	UBS	Sell
2024-01-03	Downgrade	Jefferies	Buy → Hold
2023-12-18	Iniziato	HSBC Securities	Buy
2023-09-25	Aggiornamento	Jefferies	Hold → Buy
2023-07-14	Iniziato	HSBC Securities	Buy
2023-07-12	Aggiornamento	UBS	Neutral → Buy
2023-07-05	Downgrade	Deutsche Bank	Buy → Hold
2023-04-11	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-01-05	Iniziato	BMO Capital Markets	Outperform
2022-09-15	Downgrade	Credit Suisse	Outperform → Neutral
2022-09-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-29	Aggiornamento	Argus	Hold → Buy
2022-06-14	Downgrade	UBS	Buy → Neutral
2022-02-11	Aggiornamento	DZ Bank	Sell → Hold
2021-12-07	Downgrade	Jefferies	Buy → Hold
2021-08-12	Ripresa	JP Morgan	Overweight
2021-04-12	Downgrade	Argus	Buy → Hold
2021-03-16	Aggiornamento	Jefferies	Hold → Buy
2021-02-25	Aggiornamento	UBS	Neutral → Buy
2021-01-15	Iniziato	Deutsche Bank	Buy
2020-12-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-11-30	Aggiornamento	UBS	Sell → Neutral
2020-11-11	Aggiornamento	HSBC Securities	Reduce → Hold
2020-09-29	Iniziato	Berenberg	Buy
2019-11-22	Iniziato	SVB Leerink	Outperform
2019-10-25	Aggiornamento	Liberum	Hold → Buy
2019-04-02	Downgrade	UBS	Neutral → Sell
2019-02-05	Iniziato	Exane BNP Paribas	Outperform
2019-01-25	Aggiornamento	Shore Capital	Hold → Buy
2018-12-11	Ripresa	Jefferies	Hold
2018-10-09	Iniziato	Guggenheim	Buy
2018-08-16	Downgrade	Jefferies	Buy → Hold
2018-03-19	Aggiornamento	Jefferies	Hold → Buy
2018-02-06	Reiterato	Leerink Partners	Mkt Perform
2018-02-05	Reiterato	Bernstein	Outperform
2018-01-18	Reiterato	Leerink Partners	Mkt Perform
2017-12-29	Aggiornamento	JP Morgan	Neutral → Overweight
2017-10-16	Aggiornamento	Credit Suisse	Neutral → Outperform
2017-09-25	Aggiornamento	Exane BNP Paribas	Neutral → Outperform
2017-09-22	Aggiornamento	Bernstein	Mkt Perform → Outperform

Mostra tutto

Astrazeneca Plc Borsa (AZN) Ultime notizie

12:39 PM

AstraZeneca’s DURGA-4 CAR-T Study Puts New Pressure on Multiple Myeloma Rivals - TipRanks

12:39 PM

12:34 PM

AstraZeneca Advances Pediatric Symbicort Device Study, Supporting Long Term Respiratory Strategy - TipRanks

12:34 PM

11:03 AM

AstraZeneca (AZN) Refutes Takeover Speculation - GuruFocus

11:03 AM

11:01 AM

$100 Million AstraZeneca Deal Puts Chinese Biotech Jacobio on Path to Profit - Caixin Global

11:01 AM

10:28 AM

Abivax Denies La Lettre Report of AstraZeneca Exclusivity - marketscreener.com

10:28 AM

08:18 AM

Van ECK Associates Corp Sells 72,809 Shares of AstraZeneca PLC $AZN - MarketBeat

08:18 AM

06:46 AM

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - Benzinga

06:46 AM

06:45 AM

SageView Advisory Group LLC Acquires New Holdings in AstraZeneca PLC $AZN - MarketBeat

06:45 AM

06:27 AM

AstraZeneca (AZN) Enters Exclusive Agreement Boosting Abivax Sha - GuruFocus

06:27 AM

04:27 AM

BNP Paribas Financial Markets Increases Stock Position in AstraZeneca PLC $AZN - MarketBeat

04:27 AM

04:26 AM

Capital Research Global Investors Raises Stock Holdings in AstraZeneca PLC $AZN - MarketBeat

04:26 AM

04:14 AM

AstraZeneca in pole position to acquire Abivax - marketscreener.com

04:14 AM

03:10 AM

Morgan Stanley sees double-digit EPS growth for AstraZeneca PLC (AZN) - MSN

03:10 AM

02:30 AM

Morgan Stanley Sees Double-Digit EPS Growth for AstraZeneca PLC (AZN) - Yahoo Finance

02:30 AM

Mar 11, 2026

Franklin Resources Inc. Sells 1,585,664 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 11, 2026

Russell Investments Group Ltd. Has $66.19 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat

Mar 11, 2026